Business Context and Reporting Period
This Form 8-K Current Report was filed by ReShape Lifesciences Inc. (trading symbol: RSLS) on September 18, 2024. The report details a material corporate action regarding the company's capital structure. The registrant is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a corporate governance event.
Material Changes
The primary material change reported is the implementation of a 1-for-58 reverse stock split of the company's outstanding common stock.
- Effective Date: The split became effective for trading purposes on September 23, 2024.
- Mechanism: Every 58 shares of issued and outstanding common stock were converted into one share.
- Fractional Shares: Fractional shares resulting from the split were rounded up to the nearest whole share.
- Adjustments: Proportional adjustments were made to the number of shares and exercise/conversion prices for outstanding warrants, stock options, and convertible preferred stock.
- Authorized Shares: The number of authorized shares was not reduced, increasing the number of shares available for future issuance relative to outstanding shares.
- Voting Rights: The split does not alter par value, voting rights, or other terms of the stock.
Guidance, Outlook, and Risks
The filing does not provide new financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure of the reverse split mechanics. The action was previously approved by stockholders at the annual meeting held on February 23, 2024.
Investor Verification Checklist
- Verify the adjusted share count and price per share on the Nasdaq Capital Market effective September 23, 2024.
- Confirm the adjusted exercise prices and share quantities for any held warrants, stock options, or convertible securities.
- Review the press release dated September 19, 2024 (Exhibit 99.1) for additional context on the rationale for the split.
- Check the Sixth Amendment to the Restated Certificate of Incorporation (Exhibit 3.1) for the official legal text of the amendment.